financetom
Business
financetom
/
Business
/
Top Wall Street Forecasters Revamp Circle Internet Group Expectations Ahead Of Q2 Earnings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top Wall Street Forecasters Revamp Circle Internet Group Expectations Ahead Of Q2 Earnings
Aug 12, 2025 12:14 AM

Circle Internet Group ( CRCL ) will release earnings results for the second quarter before the opening bell on Tuesday, Aug. 12.

Analysts expect the New York-based company to report quarterly earnings at 34 cents per share. Circle Internet ( CRCL ) projects to report quarterly revenue of $644.72 million, according to data from Benzinga Pro.

On Aug. 6, Corpay and Circle announced a collaboration to expand Stablecoin access.

Circle Internet ( CRCL ) shares rose 1.4% to close at $161.17 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

Baird analyst David Koning initiated coverage on the stock with a Neutral rating and a price target of $210 on July 11, 2025. This analyst has an accuracy rate of 75%.

Mizuho analyst Dan Dolev initiated coverage on the stock with an Underperform rating and a price target of $85 on July 8, 2025. This analyst has an accuracy rate of 69%.

Oppenheimer analyst Owen Lau initiated coverage on the stock with a Perform rating on June 30, 2025. This analyst has an accuracy rate of 70%.

Goldman Sachs analyst James Yaro initiated coverage on the stock with a Neutral rating and a price target of $83 on June 30, 2025. This analyst has an accuracy rate of 60%.

Deutsche Bank analyst Brian Bedell initiated coverage on the stock with a Hold rating and a price target of $155 on June 30, 2025. This analyst has an accuracy rate of 74%

Considering buying CRCL stock? Here’s what analysts think:

Read This Next:

Wall Street’s Most Accurate Analysts Give Their Take On 3 Tech And Telecom Stocks Delivering High-Dividend Yields

Photo via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NiCAN Provides Update On Drilling At The Wine Nickel-Copper Project, Manitoba
NiCAN Provides Update On Drilling At The Wine Nickel-Copper Project, Manitoba
Mar 26, 2024
12:47 PM EDT, 03/26/2024 (MT Newswires) -- NiCAN Limited ( NILTF ) announced Tuesday it has completed its late winter diamond drilling program on the Wine Property located in the Snow Lake area, Manitoba. Brad Humphrey, President and CEO, said in a statement: We are encouraged by the drilling completed so far in 2024 at the Wine Occurrence, which continues...
Moody's places Boeing's Baa2 and Prime-2 ratings on review for downgrade
Moody's places Boeing's Baa2 and Prime-2 ratings on review for downgrade
Mar 26, 2024
March 26 (Reuters) - Moody's said on Tuesday it is placing Boeing's ( BA ) Baa2 and Prime-2 ratings on review for downgrade. ...
Why Praxis Precision Medicines Stock Is Trading Higher Tuesday
Why Praxis Precision Medicines Stock Is Trading Higher Tuesday
Mar 26, 2024
Praxis Precision Medicines Inc ( PRAX ) provided an update on its Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with photo paroxysmal response (PPR), also known as photosensitivity.  PPR studies measure electroencephalogram (EEG) signatures after intermittent photic stimulation and are used as an indicator of anti-seizure efficacy. “The strength and consistency of response across both study arms, combined...
Market Chatter: Amazon Pharmacy Reaping Benefits of Demand for Anti-Obesity Drugs, Executive Says
Market Chatter: Amazon Pharmacy Reaping Benefits of Demand for Anti-Obesity Drugs, Executive Says
Mar 26, 2024
12:59 PM EDT, 03/26/2024 (MT Newswires) -- Amazon.com's ( AMZN ) online pharmacy is reaping the benefits of demand for anti-obesity drugs in the US, the Financial Times reported, citing John Love, the head of the business. Drugs such as Eli Lilly's ( LLY ) Zepbound and Novo Nordisk's ( NVO ) Wegovy would create a lot of revenue for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved